Brad Pohlman

8.3k citations

220 papers · 4.6k indexed · 1 hit paper · h-index 37

Impact in

Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation

Papers in

Hematology 83
- Hematopoietic Stem Cell Transplantation 66
- Acute Myeloid Leukemia Research 27
Pathology and Forensic Medicine 107
- Lymphoma Diagnosis and Treatment 104

Co-authors: Brian J. Bolwell Ronald Sobecks Lisa Rybicki Eric D. Hsi M Kalaycio Robert M. Dean S Andresen Leo I. Gordon
Journals: Blood (63 papers)Bone Marrow Transplantation (49 papers)Biology of Blood and Marrow Transplantation (19 papers)Journal of Clinical Oncology (9 papers)British Journal of Haematology (8 papers)
Partner nations: United States Israel United Kingdom

In The Last Decade

Brad Pohlman

216 papers receiving 4.5k citations

Hit Papers

align trajectories log scale

Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma 2002 · 841 citations

Peers

Countries citing papers authored by Brad Pohlman

Since Specialization

Citations

This map shows the geographic impact of Brad Pohlman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brad Pohlman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brad Pohlman more than expected).

Fields of papers citing papers by Brad Pohlman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brad Pohlman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brad Pohlman. The network helps show where Brad Pohlman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Brad Pohlman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Brad Pohlman Line = papers co-authored together Brad Pohlman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The association of body composition and outcomes following autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma Bone Marrow Transplantation ·Gabriel Aleixo, Wei Wei, Po‐Hao Chen, Namita Gandhi, Faiz Anwer, Robert M. Dean, Betty K. Hamilton, Brian T. Hill, Deepa Jagadeesh, Jack Khouri, Brad Pohlman, Ronald Sobecks, Allison Winter, Paolo F. Caimi, Navneet S. Majhail	2023	2
2	Toxicity analysis of busulfan pharmacokinetic therapeutic dose monitoring Journal of Oncology Pharmacy Practice ·Arni Azis Yuliyantiningsih, Theresa Urban, Ya Ji Song, Faiz Anwer, Robert M. Dean, Aaron T. Gerds, Betty K. Hamilton, Deepa Jagadeesh, Matt Kalaycio, Jack Khouri, Brad Pohlman, Ronald Sobecks, Allison Winter, Lisa Rybicki, Navneet S. Majhail, Brian T. Hill	2022	1
3	Resource Utilization and Factors Prolonging Hospitalization for Patients with Refractory and Relapsed Large B-Cell Lymphoma Receiving Tisagenlecleucel Versus Axicabtagene Ciloleucel Transplantation and Cellular Therapy ·Agrima Mian, Wei Wei, Brian T. Hill, Betty K. Hamilton, Brad Pohlman, Deepa Jagadeesh, Faiz Anwer, Matt Kalaycio, Robert M. Dean, Ronald Sobecks, Navneet S. Majhail	2021	2
4	Comparison of the Prognostic Value of Risk Assessment Tools in Allogeneic Hematopoietic Cell Transplantation Transplantation and Cellular Therapy ·Cristhian Huanca, Lisa Rybicki, Lalitya Dhimas Prima M, Daniel Ch. Haspinger, Faiz Anwer, Robert M. Dean, Brian T. Hill, Matt Kalaycio, Jack Khouri, Deepa Jagadeesh, Brad Pohlman, Ronald Sobecks, Allison Winter, Navneet S. Majhail, Betty K. Hamilton	2021	1
5	The impact of socioeconomic disparities on the use of upfront autologous stem cell transplantation for mantle cell lymphoma Leukemia & lymphoma ·Yazeed Sawalha, Tomas Radivoyevitch, Xuefei Jia, Katherine Tullio, Robert M. Dean, Brad Pohlman, Brian T. Hill, Matt Kalaycio, Navneet S. Majhail, Deepa Jagadeesh	2021	4
6	A pilot clinical trial of oral tetrahydrouridine/decitabine for noncytotoxic epigenetic therapy of chemoresistant lymphoid malignancies Seminars in Hematology ·Brian T. Hill, Deepa Jagadeesh, Brad Pohlman, Robert M. Dean, Neetha Parameswaran, Moein Ghafoori, Tomas Radivoyevitch, Xue Jun-l, N. Digellidis, Mike Vasquez, Bevilacqua M., Daniel J. Lindner, Mitchell R. Smith, Yogen Saunthararajah	2020	8
7	Results of a Phase I Trial of Lenalidomide, Rituximab (R2) and Ixazomib for Frontline Treatment of High Risk Follicular and Indolent Non-Hodgkin Lymphoma Blood ·Brian T. Hill, Deepa Jagadeesh, Alex Garcia, Robert M. Dean, Omer N. Koç, Matt Kalaycio, Kirsten M Boughan, Brenda Cooper, Allison Winter, Wesam Ahmed, Brad Pohlman, Caroline Blada, Kyle A. Wright, Xue Jun-l, Paolo F. Caimi, Mitchell R. Smith	2020	1
8	Outcomes and Factors Impacting Use of Axicabtagene Ciloleucel in Refractory and Relapsed Large B-Cell Lymphoma: An Intent-to-Treat Analysis Blood ·Agrima Mian, Wei Wei, Allison Winter, Jack Khouri, Deepa Jagadeesh, Faiz Anwer, Aaron T. Gerds, Robert M. Dean, Ronald Sobecks, Brad Pohlman, Matt Kalaycio, Betty K. Hamilton, Navneet S. Majhail, Brian T. Hill	2019	5
9	Evaluation of Corticosteroids for Engraftment Syndrome (ES) Prophylaxis in Patients Undergoing Autologous Hematopoietic Cell Transplantation (AHCT) with High-Dose Melphalan (MEL) Biology of Blood and Marrow Transplantation ·Ya Ji Song, Theresa Urban, Mee Jeong Kim, P Winward, A Licito, Robert M. Dean, Aaron T. Gerds, Betty K. Hamilton, Brian T. Hill, Deepa Jagadeesh, Matt Kalaycio, Brad Pohlman, Ronald Sobecks, Lisa Rybicki, Navneet S. Majhail	2019	1
10	Implementation of an Electronic Medical Record Tool for Early Detection of Deep Vein Thrombosis in the Ambulatory Oncology Setting: The Cleveland Clinic Experience Blood ·N. B. Patil, 西脇徹, Zoher Kadi, Lajos Salamon, Bhumika Patel, Sagar S. Patel, Julia Jarman, Dana E. Angelini, Keith R. McCrae, Brad Pohlman, Alok A. Khorana	2017	2
11	Neutropenic fever during peripheral blood progenitor cell mobilization is associated with decreased CD34+ cell collection and increased apheresis collection days Journal of Clinical Apheresis ·Jack Khouri, Lisa Rybicki, Navneet S. Majhail, Matt Kalaycio, Edward A. Copelan, Brad Pohlman, Brian T. Hill, Robert M. Dean, Aleksandr Lazaryan, Betty K. Hamilton, Steven Andrèsen, Ronald Sobecks, Brian J. Bolwell, Hien Liu	2017	6
12	Conditional Long-Term Survival Among Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Autologous Hematopoietic Cell Transplantation (AHCT) Blood ·장진태, Lisa Rybicki, Brian J. Bolwell, Mohamed A. Kharfan‐Dabaja, Robert M. Dean, Betty K. Hamilton, Rabi Hanna, Deepa Jagadeesh, Matt Kalaycio, Hien Liu, Brad Pohlman, Ronald Sobecks, Brian T. Hill, Navneet S. Majhail	2017	1
13	Outcomes in Patients with Enteropathy-Associated T-Cell Lymphoma (EATL) and Hepatosplenic T-Cell Lymphoma (HSTCL): A Population Based Analysis Using the SEER Data Blood ·Dhruvika Mukhija, Tomas Radivoyevitch, Brian T. Hill, Robert M. Dean, Brad Pohlman, Deepa Jagadeesh	2017	1
14	The Role of Upfront Autologous Hematopoietic Cell Transplantation in the Treatment of Mantle Cell Lymphoma, a Population Based Study Using the National Cancer Data Base (NCDB) Blood ·Yazeed Sawalha, Tomas Radivoyevitch, Katherine Tullio, Robert M. Dean, Brad Pohlman, Brian T. Hill, Matt Kalaycio, Navneet S. Majhail, Deepa Jagadeesh	2017	5
15	Predictors for Recurrent 30-Day Unplanned Readmissions in Patients with Hematologic Malignancies Blood ·N. B. Patil, Hina Ahmed, Sagar S. Patel, Bhumika Patel, Paul Elson, Heng-Feng Long, Aaron T. Gerds, Hetty E. Carraway, Anjali S. Advani, Aziz Nazha, Alberto J. Montero, Brad Pohlman, Fushan Ci, Clovis Raymundo Maliska, Julia Jarman, Katherine Tullio, Kimberly Bell, Matt Kalaycio, Mikkael A. Sekeres, Sudipto Mukherjee	2017	1
16	A Phase II trial of Belinostat ( PXD 101) in patients with relapsed or refractory peripheral or cutaneous T‐cell lymphoma British Journal of Haematology ·Francine M. Foss, Ranjana H. Advani, Madeleine Duvic, Kenneth B. Hymes, Tanin Intragumtornchai, Arnuparp Lekhakula, Ofer Shpilberg, Adam Lerner, Robert J. Belt, Eric D. Jacobsen, Guy Laurent, Dina Ben‐Yehuda, M. Beylot‐Barry, Uwe Hillen, Poul Knoblauch, Gajanan Bhat, Shanta Chawla, Lee F. Allen, Brad Pohlman	2014	161
17	Results of a Phase 1 Study of AME-133v (LY2469298), an Fc-Engineered Humanized Monoclonal Anti-CD20 Antibody, in FcγRIIIa-Genotyped Patients with Previously Treated Follicular Lymphoma Clinical Cancer Research ·Andres Forero‐Torres, Sven de Vos, Brad Pohlman, James Bellak, Damien M. Cronier, Nam H. Dang, Susan P. Carpenter, Barrett W. Allan, 邱轶先, Christopher A. Slapak, Mitchell R. Smith, Brian K. Link, James E. Wooldridge, Kristen N. Ganjoo	2012	54
18	Follicular programmed death 1–positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma Human Pathology ·Gen Yin, Brad Pohlman, Paul Elson, Eric D. Hsi	2011	91
19	External Beam Radiotherapy followed by Y90 Ibritumomab Tiuxetan in Relapsed Bulky Follicular Lymphoma International Journal of Radiation OncologyBiologyPhysics ·Michael J. Burdick, Abdul Hussein Mahdi AlJibouri, Brad Pohlman, C.A. Reddy, Rahul D. Tendulkar, Roger M. Macklis	2009	0
20	Elevated Ferritin Is Associated with Relapse after Autologous Hematopoietic Stem Cell Transplantation for Lymphoma Biology of Blood and Marrow Transplantation ·Anuj Mahindra, Brian J. Bolwell, Ronald Sobecks, Lisa Rybicki, Brad Pohlman, Robert M. Dean, Steve Andresen, John Sweetenham, Matt Kalaycio, Edward A. Copelan	2008	36

About Brad Pohlman

Brad Pohlman is a scholar working on Hematology, Pathology and Forensic Medicine, Genetics, Oncology and Transplantation, having authored 220 papers that have together received 4.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (104 papers), Hematopoietic Stem Cell Transplantation (66 papers), Chronic Lymphocytic Leukemia Research (39 papers), Viral-associated cancers and disorders (35 papers), Acute Lymphoblastic Leukemia research (33 papers), Acute Myeloid Leukemia Research (27 papers), Neutropenia and Cancer Infections (18 papers) and CAR-T cell therapy research (18 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.1k citations), Hematology (1.1k citations), Genetics (904 citations), Oncology (1.9k citations) and Transplantation (118 citations). Brad Pohlman has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Brian J. Bolwell, Ronald Sobecks, Lisa Rybicki, Eric D. Hsi, M Kalaycio, Robert M. Dean, S Andresen, Leo I. Gordon, Thomas E. Witzig and Christos Emmanouilides. Their work appears in journals such as Blood, Bone Marrow Transplantation, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact